propranolol has been researched along with Aggression in 64 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although several reports suggest that intermediate to high doses of propranolol (80-160 and 200-600 mg/day) can effectively treat aggressive behavior in dementia, significant side effects can occur at these doses." | 7.69 | Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. ( Cotman, CW; Nielson, KA; Shankle, WR, 1995) |
| "A ten year old boy developed features of Tourette syndrome while taking haloperidol for behaviour problems." | 7.68 | A case of Tourette syndrome developing during haloperidol treatment. ( Karagianis, JL; Nagpurkar, R, 1990) |
| "The effect of antiaggressive agents on self-injurious behavior (SIB) was retrospectively assessed by studying the charts of mentally retarded individuals with both aggression and SIB who had been treated with either lithium (n = 11) or propranolol (n = 6)." | 7.67 | Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded. ( Dojka, D; Luchins, DJ, 1989) |
| "(+/-)Propranolol (1, 3, 10 and 30 mg/kg) exhibited a differential effect on footshock aggression (FSA) in rats." | 7.67 | Involvement of brain transmitters in the modulation of shock-induced aggression in rats by propranolol and related drugs. ( Alkondon, M; Ray, A; Sen, P, 1987) |
| "Although several reports suggest that intermediate to high doses of propranolol (80-160 and 200-600 mg/day) can effectively treat aggressive behavior in dementia, significant side effects can occur at these doses." | 3.69 | Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. ( Cotman, CW; Nielson, KA; Shankle, WR, 1995) |
| "REM sleep deprivation (REMSD) results in behavioral changes such as the appearance of affective aggression induced by apomorphine (APO) and other dopaminergic agents." | 3.68 | Effects of selective adrenoceptor agonists and antagonists on aggressive behavior elicited by apomorphine, DL-dopa and fusaric acid in REM-sleep-deprived rats. ( Troncone, LR; Tufik, S, 1991) |
| "A ten year old boy developed features of Tourette syndrome while taking haloperidol for behaviour problems." | 3.68 | A case of Tourette syndrome developing during haloperidol treatment. ( Karagianis, JL; Nagpurkar, R, 1990) |
| "The effect of antiaggressive agents on self-injurious behavior (SIB) was retrospectively assessed by studying the charts of mentally retarded individuals with both aggression and SIB who had been treated with either lithium (n = 11) or propranolol (n = 6)." | 3.67 | Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded. ( Dojka, D; Luchins, DJ, 1989) |
| "(+/-)Propranolol (1, 3, 10 and 30 mg/kg) exhibited a differential effect on footshock aggression (FSA) in rats." | 3.67 | Involvement of brain transmitters in the modulation of shock-induced aggression in rats by propranolol and related drugs. ( Alkondon, M; Ray, A; Sen, P, 1987) |
| "As part of a pilot study to assess the efficacy of propranolol in the treatment of aggression in psychiatric patients, drug interactions of propranolol with other agents were estimated by blood level monitoring." | 3.67 | Elevation of thioridazine plasma levels by propranolol. ( Katz, BL; Kogan, M; Silver, JM; Yudofsky, SC, 1986) |
| "The diagnosis of attention deficit disorder predicted preferential response to propranolol, and a diagnosis of intermittent explosive disorder predicted preferential response to carbamazepine." | 2.67 | Comparative effectiveness of carbamazepine and propranolol for rage outbursts. ( Mattes, JA, 1990) |
| "Pindolol treatment was associated with significant therapeutic benefits without sedation and without the use-limiting side effects that occur with propranolol." | 2.66 | Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. ( Greendyke, RM; Kanter, DR, 1986) |
| "Propranolol was administered every 4 h (six times per day), starting with single doses of 20-40 mg." | 2.64 | [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)]. ( Fritsch, W; Rackensperger, W; Schwarz, D; Stutte, KH; Zerssen, D, 1976) |
| "Propranolol has been proposed as a promising treatment for this cause of violent behavior." | 2.37 | Therapeutic use of propranolol for intermittent explosive disorder. ( Jenkins, SC; Maruta, T, 1987) |
| " Chronic administration of the synthetic gonadotropin (luteinising hormone) releasing hormone analogue, goserelin, reduces testosterone activity." | 1.33 | Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report. ( Raskind, MA; Rosin, RA, 2005) |
| " The overall increase in aggression observed following dosing with propranolol was not expected from a review of the clinical literature." | 1.29 | Propranolol-induced increases in target-biting attack. ( Matray-Devoti, J; Wagner, GC, 1993) |
| " No change in fighting or Bmax was observed with the chronic administration of d-propranolol (5 mg/kg bid) or metoprolol (10 mg/kg bid)." | 1.27 | Increased shock-induced fighting with supersensitive beta-adrenergic receptors. ( Eichelman, B; Hegstrand, LR, 1983) |
| " Socially dominant animals had (as in previous studies) significantly exacerbated CAA, but only in the untreated segment; the effect of social dominance on CAA was abolished by long-term administration of propranolol." | 1.27 | Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. ( Adams, MR; Clarkson, TB; Kaplan, JR; Manuck, SB; Weingand, KW, 1987) |
| "d-Indenolol was less active than dl-indenolol in lowering of methamphetamine group toxicity and calming of fighting behavior, though muscle relaxant, hypolocomotive and anticonvulsant effects of d-indenolol were virtually equal to those of the racemate." | 1.26 | Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits. ( Maeno, H; Tachikawa, S; Takenaka, T, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (67.19) | 18.7374 |
| 1990's | 13 (20.31) | 18.2507 |
| 2000's | 4 (6.25) | 29.6817 |
| 2010's | 4 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagar-Ouriaghli, I | 1 |
| Lievesley, K | 1 |
| Santosh, PJ | 1 |
| Matuskey, D | 1 |
| Sondik, T | 1 |
| Zamzow, RM | 1 |
| Ferguson, BJ | 1 |
| Stichter, JP | 1 |
| Porges, EC | 1 |
| Ragsdale, AS | 1 |
| Lewis, ML | 1 |
| Beversdorf, DQ | 1 |
| Scotti, MA | 1 |
| Lee, G | 1 |
| Gammie, SC | 1 |
| Fleminger, S | 2 |
| Greenwood, RJ | 2 |
| Oliver, DL | 2 |
| Rosin, RA | 1 |
| Raskind, MA | 1 |
| Weinstock, M | 1 |
| Weiss, C | 1 |
| Sheard, MH | 2 |
| Eichelman, B | 2 |
| Hegstrand, LR | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Greendyke, RM | 3 |
| Schuster, DB | 2 |
| Wooton, JA | 1 |
| Beatty, WW | 1 |
| Costello, KB | 1 |
| Berry, SL | 1 |
| Hara, C | 1 |
| Watanabe, S | 1 |
| Ueki, S | 2 |
| Mogilnicka, E | 1 |
| Dooley, DJ | 1 |
| Boissard, CG | 1 |
| Delini-Stula, A | 1 |
| Ratey, JJ | 3 |
| Morrill, R | 1 |
| Oxenkrug, G | 1 |
| Prakash, R | 1 |
| Campbell, TW | 1 |
| Petrie, WM | 1 |
| Prasad, V | 1 |
| Yamamoto, T | 1 |
| Shibata, S | 1 |
| Yudofsky, S | 1 |
| Williams, D | 1 |
| Gorman, J | 1 |
| Matsumoto, K | 1 |
| Ojima, K | 1 |
| Ohta, H | 1 |
| Watanabe, H | 1 |
| Gillette, DW | 1 |
| Tannery, LP | 1 |
| Matray-Devoti, J | 1 |
| Wagner, GC | 1 |
| Shankle, WR | 1 |
| Nielson, KA | 1 |
| Cotman, CW | 1 |
| Bamshad, M | 1 |
| Cooper, TT | 1 |
| Karom, M | 1 |
| Albers, HE | 1 |
| Silver, JM | 2 |
| Yudofsky, SC | 2 |
| Slater, JA | 1 |
| Gold, RK | 1 |
| Stryer, BL | 1 |
| Williams, DT | 1 |
| Wolland, H | 1 |
| Endicott, J | 1 |
| Poindexter, AR | 1 |
| Albert, DJ | 1 |
| Richmond, SE | 1 |
| Tachikawa, S | 1 |
| Takenaka, T | 1 |
| Maeno, H | 1 |
| Hine, B | 1 |
| Wallach, MB | 1 |
| Gershon, S | 1 |
| Elliott, FA | 1 |
| Rackensperger, W | 1 |
| Fritsch, W | 1 |
| Schwarz, D | 1 |
| Stutte, KH | 1 |
| Zerssen, D | 1 |
| Brooke, MM | 1 |
| Patterson, DR | 1 |
| Questad, KA | 1 |
| Cardenas, D | 1 |
| Farrel-Roberts, L | 1 |
| Gao, B | 1 |
| Cutler, MG | 1 |
| Troncone, LR | 1 |
| Tufik, S | 1 |
| Ruedrich, SL | 1 |
| Grush, L | 1 |
| Wilson, J | 1 |
| Mattes, JA | 3 |
| Abraham, G | 1 |
| Jarrett, F | 1 |
| Karagianis, JL | 1 |
| Nagpurkar, R | 1 |
| Eimer, M | 1 |
| Luchins, DJ | 1 |
| Dojka, D | 1 |
| Haas, JF | 1 |
| Cope, DN | 1 |
| Yoshimura, H | 1 |
| Ogawa, N | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Sorgi, PJ | 2 |
| Polakoff, S | 1 |
| Stewart, JT | 2 |
| Mounts, ML | 1 |
| Clark, RL | 1 |
| Volavka, J | 1 |
| Grizenko, N | 1 |
| Vida, S | 1 |
| Kuperman, S | 1 |
| Stewart, MA | 1 |
| Kanter, DR | 2 |
| Verstreate, S | 1 |
| Wootton, J | 1 |
| Jenkins, SC | 1 |
| Maruta, T | 1 |
| Ray, A | 1 |
| Alkondon, M | 1 |
| Sen, P | 1 |
| Poli, A | 1 |
| Palermo-Neto, J | 1 |
| Kaplan, JR | 1 |
| Manuck, SB | 1 |
| Adams, MR | 1 |
| Weingand, KW | 1 |
| Clarkson, TB | 1 |
| Polakoff, SA | 1 |
| Kogan, M | 1 |
| Katz, BL | 1 |
| LeFever, FF | 1 |
| Papeschi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trial of Propranolol in Older Adults With Primary Progressive Aphasia[NCT06066710] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2024-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for propranolol and Aggression
| Article | Year |
|---|---|
Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders.
Topics: Adolescent; Adrenergic beta-Antagonists; Aggression; Autism Spectrum Disorder; Autonomic Nervous Sys | 2018 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2003 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2006 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; C | 1984 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aggression; Dose-Response Relationship, Dr | 1990 |
Management of the behavioral symptoms associated with dementia.
Topics: Aged; Aggression; Antipsychotic Agents; Dementia; Humans; Pindolol; Propranolol; Psychomotor Agitati | 1989 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
Can aggressive behavior in humans be modified by beta blockers?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aggression; Animals; Brain Diseases; Child; Female; | 1988 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind | 1986 |
Therapeutic use of propranolol for intermittent explosive disorder.
Topics: Adolescent; Adult; Aggression; Female; Humans; Male; Middle Aged; Periodicity; Propranolol; Violence | 1987 |
9 trials available for propranolol and Aggression
| Article | Year |
|---|---|
Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aggression; Anxiety; Autism Spectrum Disorder; Auton | 2016 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Propranolol treatment of chronically hospitalized aggressive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Chronic Disease; Double-Blind Method; Female; Hospit | 1999 |
[The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].
Topics: Adolescent; Adult; Aggression; Bipolar Disorder; Blood Pressure; Electrocardiography; Female; Heart | 1976 |
The treatment of agitation during initial hospitalization after traumatic brain injury.
Topics: Aggression; Brain Injuries; Humans; Propranolol; Psychomotor Agitation; Restraint, Physical | 1992 |
Comparative effectiveness of carbamazepine and propranolol for rage outbursts.
Topics: Adolescent; Adult; Aggression; Antisocial Personality Disorder; Attention Deficit Disorder with Hype | 1990 |
Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study.
Topics: Adult; Aged; Aggression; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relati | 1986 |
Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study.
Topics: Adult; Aged; Aggression; Clinical Trials as Topic; Double-Blind Method; Hospitalization; Humans; Imp | 1986 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind | 1986 |
46 other studies available for propranolol and Aggression
| Article | Year |
|---|---|
Memory reconsolidation for treatment-resistant aggression and self-injurious behaviors.
Topics: Aggression; Cognitive Behavioral Therapy; Humans; Male; Memory; Mental Recall; Middle Aged; Proprano | 2015 |
Maternal defense is modulated by beta adrenergic receptors in lateral septum in mice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aggression; Animals; Atenolol; Choice Behavio | 2011 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarbo | 2005 |
Antagonism by propranolol of isolation-induced aggression in mice: correlation with 5-hydroxytryptamine receptor blockade.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Antagonists; Aggression; Animals; Behavior, Animal; Drug Intera | 1980 |
Drug regimens facilitating aggression: behavior, amine, and receptor alterations [proceedings].
Topics: Aggression; Animals; Behavior, Animal; Brain Chemistry; Diet; Humans; Male; Propranolol; Rats; Recep | 1981 |
Increased shock-induced fighting with supersensitive beta-adrenergic receptors.
Topics: Aggression; Animals; Brain; Cell Membrane; Electroshock; Haloperidol; Humans; Male; Metoprolol; Pind | 1983 |
Propranolol in the treatment of assaultive patients with organic brain disease.
Topics: Adult; Aged; Aggression; Humans; Male; Middle Aged; Neurocognitive Disorders; Propranolol | 1984 |
Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors.
Topics: Aggression; alpha-Methyltyrosine; Animals; Catecholamines; Chlorpromazine; Clonidine; Dextroamphetam | 1984 |
Anti-muricide mechanisms of chlorpromazine and imipramine in OB rats: adrenoceptors and hypothalamic functions.
Topics: Aggression; Animals; Catalepsy; Chlorpromazine; Electroencephalography; Humans; Hypothalamus; Imipra | 1984 |
Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin.
Topics: 5-Hydroxytryptophan; Aggression; Amines; Animals; Benzylamines; Drug Interactions; Electroshock; Hum | 1983 |
Use of propranolol for provoked and unprovoked episodes of rage.
Topics: Adult; Aggression; Anger; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Propranolol; | 1983 |
Psychoses with propranolol: a case report.
Topics: Adult; Aggression; Dose-Response Relationship, Drug; Humans; Intellectual Disability; Male; Proprano | 1983 |
Synergistic effect of propranolol and quipazine on desipramine enhanced shock-elicited fighting in rats.
Topics: Aggression; Animals; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Hu | 1983 |
Effects of locus coeruleus stimulation on muricide in olfactory bulbectomized and raphe lesioned rats.
Topics: Aggression; Animals; Brain Stem; Electric Stimulation; Humans; Locus Coeruleus; Male; Mice; Olfactor | 1982 |
Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes.
Topics: Adolescent; Adult; Aggression; Anger; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; P | 1981 |
Beta 2- but not beta 1-adrenoceptors are involved in desipramine enhancement of aggressive behavior in long-term isolated mice.
Topics: Aggression; Animals; Clenbuterol; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; | 1994 |
Beta blocker inhibits tricyclic metabolism.
Topics: Adrenergic beta-Antagonists; Aggression; Anger; Antidepressive Agents, Tricyclic; Child; Depressive | 1994 |
Propranolol-induced increases in target-biting attack.
Topics: Aggression; Animals; Dose-Response Relationship, Drug; Male; Mice; Propranolol; Serotonin; Stimulati | 1993 |
Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients.
Topics: Aged; Aggression; Alzheimer Disease; Dementia; Female; Humans; Male; Middle Aged; Propranolol; Psych | 1995 |
Glutamate and vasopressin interact to control scent marking in Syrian hamsters (Mesocricetus auratus).
Topics: 2-Amino-5-phosphonovalerate; Adrenergic beta-Antagonists; Aggression; Animals; Arginine Vasopressin; | 1996 |
Phenobarbital, propranolol, and aggression.
Topics: Aggression; Anti-Anxiety Agents; Anticonvulsants; Humans; Phenobarbital; Propranolol; Psychomotor Ag | 2000 |
Reactivity and aggression in the rat: induction by alpha-adrenergic blocking agents injected ventral to anterior septum but not into lateral septum.
Topics: Adrenergic alpha-Antagonists; Aggression; Anesthesia, Local; Animals; Atropine; Haloperidol; Humans; | 1977 |
Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
Topics: Adrenergic beta-Antagonists; Aggression; Animals; Behavior, Animal; Blood Pressure; Central Nervous | 1978 |
Involvement of biogenic amines in drug-induced aggressive pecking in chicks.
Topics: Aggression; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Amines; Chickens; Dextroamphe | 1975 |
Propranolol for the control of belligerent behavior following acute brain damage.
Topics: Adult; Aggression; Brain Concussion; Brain Injuries; Cerebrovascular Disorders; Humans; Male; Middle | 1977 |
Effects of acute and subchronic administration of propranolol on the social behaviour of mice; an ethopharmacological study.
Topics: Aggression; Animals; Drinking Behavior; Exploratory Behavior; Injections, Intraperitoneal; Male; Mic | 1992 |
Effects of selective adrenoceptor agonists and antagonists on aggressive behavior elicited by apomorphine, DL-dopa and fusaric acid in REM-sleep-deprived rats.
Topics: Aggression; Animals; Apomorphine; Brain; Dihydroxyphenylalanine; Fusaric Acid; Isoproterenol; Norepi | 1991 |
Propranolol in the treatment of postencephalitic psychosis.
Topics: Adolescent; Aggression; Encephalitis; Female; Humans; Neurocognitive Disorders; Propranolol | 1990 |
A case of Tourette syndrome developing during haloperidol treatment.
Topics: Aggression; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combina | 1990 |
Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
Topics: Adult; Aggression; Female; Humans; Lithium; Male; Mental Disorders; Middle Aged; Propranolol; Self M | 1989 |
Neuropharmacologic management of behavior sequelae in head injury: a case report.
Topics: Adult; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Behavior; Craniocerebral Trauma; Human | 1985 |
[Pharmaco-ethological analysis of agonistic behavior between resident and intruder mice: effects of adrenergic beta-blockers].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aggression; Agonistic Behavior; Animals; Anti-An | 1985 |
Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Chronic Disease; Female; Humans; Male; Middle Aged; | 1986 |
Aggressive behavior in Huntington's disease: treatment with propranolol.
Topics: Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Huntington | 1987 |
Beta-adrenergic blockers for aggressive behavior in schizophrenia.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Hum | 1987 |
Paradoxical aggressive effect of propranolol in a patient with Huntington's disease.
Topics: Aged; Aggression; Humans; Huntington Disease; Male; Neurocognitive Disorders; Propranolol | 1987 |
Propranolol treatment of episodic dyscontrol and aggressive behavior in children.
Topics: Aggression; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Humans; Male; Propran | 1988 |
Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome.
Topics: Adolescent; Adult; Aggression; Child; Child Behavior Disorders; Child, Preschool; Female; Humans; Ma | 1987 |
Involvement of brain transmitters in the modulation of shock-induced aggression in rats by propranolol and related drugs.
Topics: Acetylcholinesterase; Aggression; Albuterol; Animals; Atropine; Brain; Electroshock; Male; Physostig | 1987 |
Effects of d,1-propranolol and haloperidol on aggressive behavior induced in mice by isolation and isolation plus amphetamine treatment.
Topics: Aggression; Agonistic Behavior; Amphetamine; Animals; Haloperidol; Mice; Propranolol; Social Isolati | 1986 |
Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet.
Topics: Aggression; Animals; Blood Pressure; Coronary Disease; Diet, Atherogenic; Heart Rate; Lipids; Macaca | 1987 |
The treatment of impulsive and aggressive behavior with nadolol.
Topics: Adult; Aggression; Humans; Impulsive Behavior; Intellectual Disability; Male; Nadolol; Propanolamine | 1986 |
Elevation of thioridazine plasma levels by propranolol.
Topics: Adult; Aggression; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mental Disord | 1986 |
Propranolol in ataxia and in aggression: central actions.
Topics: Aggression; Ataxia; Brain; Humans; Propranolol | 1986 |
Metoprolol for intermittent explosive disorder.
Topics: Adult; Aggression; Anger; Carbamazepine; Humans; Male; Metoprolol; Neurocognitive Disorders; Propran | 1985 |
An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
Topics: 5-Hydroxytryptophan; Aggression; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Bens | 1974 |